Miller Financial Services’s Citius Pharmaceuticals CTXR Stock Holding History

Miller Financial Services’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$81.8K	Buy	154,000 +24,000	+18%	+$14.1K	0.06%	143
2026 Q2	$78.6K	Buy	130,000 +116,000	+829%	+$78.5K	0.06%	138
2026 Q1	$12.6K	Buy	+14,000	New	+$11.3K	0.01%	118

Other funds holding CTXR

Asset Advisory Group Kinnelon, New Jersey $232M AUM 16.51% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Princeton Global Asset Management Princeton, New Jersey $692M AUM 20.31% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Miller Financial Services's CTXR Position: Q3 2026 in Review

Miller Financial Services increased its Citius Pharmaceuticals (CTXR) stake by 18% in Q3 2026, buying an estimated $14.1K and bringing the position to 154,000 shares worth $81.8K. The position accounts for 0.06% of the portfolio, ranked #143.

Miller Financial Services first reported a position in CTXR in Q1 2026 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold CTXR as of Q3 2026.

Miller Financial Services held 154,000 shares of Citius Pharmaceuticals worth $81.8K as of Q3 2026.
Miller Financial Services bought 24,000 Citius Pharmaceuticals shares in Q3 2026, an estimated $14.1K.
Citius Pharmaceuticals made up 0.06% of Miller Financial Services's portfolio in Q3 2026, its #143 holding.
Miller Financial Services first reported a position in Citius Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
6 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2026.

Based on Miller Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.